Table 2 Clinical features and outcome of patients infected with NDM-producing vs. non-NDM Carbapenem-resistant Acinetobacter baumannii
Variable | NDM-A. baumannii (n = 54) | Non-NDM A. baumannii (n = 108) | p-value |
|---|---|---|---|
Any isolation from clinical site, N (%) | 19 (35) | 45 (41) | 0.42 |
Any isolation form blood, N (%) | 5 (9.3) | 8 (7.4) | 0.68 |
Isolation from clinical sites in carriers, N (%) | 6 (14.6) | 16 (20.5) | 0.43 |
Time from colonization to clinical infection, median days (95% C.I.) | 13 (2.2–23.8) | 7 (3-10.9) | 0.31 |
In-hospital mortality, N (%) | 23 (42.6) | 36 (33) | 0.24 |
Length of stay, mean (S.D.) | 48.5 (59) | 36 (36.5) | 0.097 |